The case for and concerns about continuous dopamine stimulation in Parkinson's disease.

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Delivery of levodopa or other dopaminergic agents to the striatum is a critical determinant of the clinical response and may account for many of the fluctations in response ("on-off"). This should be manageable with innovative delivery systems for the drugs. However further studies are required to determine if continuous dopaminergic stimulation will be complicated by increased levels of drug metabolites or down regulation of dopaminergic neurotransmission.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalJournal of neural transmission. Supplementum
Volume27
StatePublished - 1988

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'The case for and concerns about continuous dopamine stimulation in Parkinson's disease.'. Together they form a unique fingerprint.

  • Cite this